Results 21 to 30 of about 101,444 (326)

Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020 [PDF]

open access: yesEndocrinology and Metabolism, 2021
Over the last two decades, our understanding of diabetes and treatment strategies have evolved tremendously, from scientific, mechanistic, and human perspectives.
Eun-Jung Rhee   +2 more
doaj   +1 more source

Risk Assessment of Dyslipidemias, Hyperglycemia, Hyperuricemia, and Hypertension Utilizing Self-Reported Body Silhouettes

open access: yesJournal of Obesity, 2023
Objective. Self-reported body silhouette is an anthropometric instrument that has been utilized as a screening tool for underweight, overweight, obesity, and other abnormal anthropometric variables.
Ruben Blachman-Braun   +6 more
doaj   +1 more source

Editorial: Secondary Dyslipidemias [PDF]

open access: yesThe Open Cardiovascular Medicine Journal, 2011
The term “secondary dyslipidemias” is used to describe the quantitative and/or qualitative alterations in lipoprotein metabolism that complicate the course of other medical disorders. Although the precise prevalence of secondary dyslipidemias has not been determined, the increasing incidence of the conditions that predispose to their development (such ...
Elisaf, M. S., Tsimihodimos, V.
openaire   +3 more sources

Lipid profile of Mexican children with Down syndrome

open access: yesBMC Pediatrics, 2021
Introduction Down syndrome (DS) is associated with various congenital anomalies and metabolic alterations, such as dyslipidemias, that can lead to cardiovascular disease in adulthood.
Silvestre Garcia-de la Puente   +3 more
doaj   +1 more source

Contribution of Known Genetic Risk Variants to Dyslipidemias and Type 2 Diabetes in Mexico: A Population-Based Nationwide Study

open access: yesGenes, 2020
Dyslipidemias are common risk factors for the development of chronic disorders including type 2 diabetes (T2D). Over 100 associated loci have been identified but few reports have evaluated the population attributable fraction captured by them in ...
A. Huerta-Chagoya   +11 more
semanticscholar   +1 more source

Atherogenic dyslipidemia

open access: yesIndian Journal of Endocrinology and Metabolism, 2013
Atherogenic dyslipidemia (AD) refers to elevated levels of triglycerides (TG) and small-dense low-density lipoprotein and low levels of high-density lipoprotein cholesterol (HDL-C). In addition, elevated levels of large TG rich very low-density lipoproteins, apolipoprotein B and oxidised low-density lipoprotein (LDL), and reduced levels of small high ...
C N Manjunath   +3 more
openaire   +3 more sources

Dyslipidemias in diabetes

open access: yesСахарный диабет, 2004
Cardiovascular diseases (CVD) are responsible for 75% of the morbidity and mortality in patients with type 2 diabetes. Diabetes accelerates plaque formation and progression in coronary, cerebrovascular and peripheral arteries.
HELENA W RODBARD
doaj   +1 more source

Evaluation of Lipid Profiles of Children and Youth from Basic Health Units in Campinas, SP, Brazil: A Cross-Sectional Laboratory Study [PDF]

open access: yesArquivos Brasileiros de Cardiologia
Background: Among dyslipidemias, hypercholesterolemia is considered the main risk factor for cardiovascular diseases in adults. In childhood and adolescence, elevated total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) are positively ...
Érica Ivana Lázaro Gomes   +2 more
doaj   +3 more sources

Is long-term PM1 exposure associated with blood lipids and dyslipidemias in a Chinese rural population?

open access: yesEnvironment International, 2020
Background: Air pollution has been shown to be associated with blood lipid levels. However, studies on long-term ambient particulate matter with aerodynamic diameter ≤1 μm (PM1) exposure in high-exposure areas are still limited.
Shuyuan Mao   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy